European Journal of Experimental Biology Open Access

  • ISSN: 2248-9215
  • Journal h-index: 45
  • Journal CiteScore: 34.35
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Articles published in European Journal of Experimental Biology have been cited by esteemed scholars and scientists all around the world. European Journal of Experimental Biology has got h-index 45, which means every article in European Journal of Experimental Biology has got 45 average citations.

Following are the list of articles that have cited the articles published in European Journal of Experimental Biology.

  2021 2020 2019 2018 2017 2016

Year wise published articles

33 22 20 35 42 53

Year wise citations received

1416 1346 1310 1210 1156 951
Journal total citations count 11765
Journal cite score 34.35
Journal h-index 45
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal citescore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
Important citations
Choukroun G, Hajjar R, Kyriakis JM, Bonventre JV, Rosenzweig A, Force T. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy. The Journal of clinical investigation. 1998 Oct 1;102(7):1311-20.
Perdiguero E, Ruiz?Bonilla V, Gresh L, Hui L, Ballestar E, Sousa?Victor P, Baeza?Raja B, Jardí M, Bosch?Comas A, Esteller M, Caelles C. Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38? in abrogating myoblast proliferation. The EMBO journal. 2007 Mar 7;26(5):1245-56.
Liang Q, Molkentin JD. Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models. Journal of molecular and cellular cardiology. 2003 Dec 1;35(12):1385-94.
De Windt LJ, Lim HW, Haq S, Force T, Molkentin JD. Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart: cross-talk between cardiac hypertrophic signaling pathways. Journal of Biological Chemistry. 2000 May 5;275(18):13571-9.
Charron F, Tsimiklis G, Arcand M, Robitaille L, Liang Q, Molkentin JD, Meloche S, Nemer M. Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA. Genes & development. 2001 Oct 15;15(20):2702-19.
Morisco C, Zebrowski D, Condorelli G, Tsichlis P, Vatner SF, Sadoshima J. The Akt-glycogen synthase kinase 3? pathway regulates transcription of atrial natriuretic factor induced by ?-adrenergic receptor stimulation in cardiac myocytes. Journal of Biological Chemistry. 2000 May 12;275(19):14466-75.
Rohini A, Agrawal N, Koyani CN, Singh R. Molecular targets and regulators of cardiac hypertrophy. Pharmacological research. 2010 Apr 1;61(4):269-80.
Fischer P, Hilfiker-Kleiner D. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis. Basic research in cardiology. 2007 Sep 1;102(5):393-411.
MacLellan WR, Schneider MD. Genetic dissection of cardiac growth control pathways. Annual review of physiology. 2000 Mar;62(1):289-320.
Zhang D, Gaussin V, Taffet GE, Belaguli NS, Yamada M, Schwartz RJ, Michael LH, Overbeek PA, Schneider MD. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nature medicine. 2000 May;6(5):556-63.
Purcell NH, Tang G, Yu C, Mercurio F, DiDonato JA, Lin A. Activation of NF-?B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proceedings of the National Academy of Sciences. 2001 Jun 5;98(12):6668-73.
Braz JC, Bueno OF, Liang Q, Wilkins BJ, Dai YS, Parsons S, Braunwart J, Glascock BJ, Klevitsky R, Kimball TF, Hewett TE. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling. The Journal of clinical investigation. 2003 May 15;111(10):1475-86.
Taigen T, De Windt LJ, Lim HW, Molkentin JD. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proceedings of the National Academy of Sciences. 2000 Feb 1;97(3):1196-201.
Hirotani S, Otsu K, Nishida K, Higuchi Y, Morita T, Nakayama H, Yamaguchi O, Mano T, Matsumura Y, Ueno H, Tada M. Involvement of nuclear factor-?B and apoptosis signal-regulating kinase 1 in G-protein–coupled receptor agonist–induced cardiomyocyte hypertrophy. Circulation. 2002 Jan 29;105(4):509-15.
Akazawa H, Komuro I. Roles of cardiac transcription factors in cardiac hypertrophy. Circulation research. 2003 May 30;92(10):1079-88.
.
Lin A. Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays. 2003 Jan;25(1):17-24.
Sugden PH, Clerk A. Cellular mechanisms of cardiac hypertrophy. Journal of molecular medicine. 1998 Sep 1;76(11):725-46.
Molkentin JD. Calcineurin–NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovascular research. 2004 Aug 15;63(3):467-75.
.